The general public should therefore have access to information in the product database, the pharmacovigilance database and the manufacturing and wholesale distribution database, after the deletion of any commercially confidential information by the competent authority.
Ba cheart, dá bhrí sin, rochtain a bheith ag an bpobal i gcoitinne ar an bhfaisnéis sa bhunachar sonraí táirgí, sa bhunachar sonraí faireachais cógas agus sa bhunachar sonraí monaraíochta agus dáileacháin mórdhíola, tar éis don údarás inniúil aon fhaisnéis rúnda tráchtála a scriosadh.